Between the years 2026 to 2036, it is anticipated that the market for insulin resistance will experience consistent growth. Analysis by DelveInsight indicates that this growth is primarily fueled by the escalating global rates of obesity and type 2 diabetes. Furthermore, the increasing recognition of insulin resistance as a key factor in these conditions is contributing to the market expansion.